| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |